Bennett Julia S, Griffiths David T, McCarthy Noel D, Sleeman Karen L, Jolley Keith A, Crook Derrick W, Maiden Martin C J
The Peter Medawar Building for Pathogen Research and Department of Zoology, University of Oxford, South Parks Rd., Oxford OX1 3SY, United Kingdom.
Infect Immun. 2005 Apr;73(4):2424-32. doi: 10.1128/IAI.73.4.2424-2432.2005.
Neisseria lactamica, a harmless human commensal found predominantly in the upper respiratory tracts of infants, is closely related to Neisseria meningitidis, a pathogen of global significance. Colonization with N. lactamica may be responsible for the increase in immunity to meningococcal disease that occurs during childhood, when rates of meningococcal carriage are low. This observation has led to the suggestion that N. lactamica whole cells or components are potential constituents of novel meningococcal vaccines. However, the dynamics of carriage and population diversity of N. lactamica in children are poorly understood, presenting difficulties for the choice of representative isolates for use in vaccine development. This problem was addressed by the multilocus sequence typing of N. lactamica isolates from two longitudinal studies of bacterial carriage in infants. The studies comprised 100 and 216 subjects, with N. lactamica carriage monitored from age 4 weeks until age 96 weeks and from age 2 weeks until age 24 weeks, respectively. The maximum observed carriage rate was 44% at 56 weeks of age, with isolates obtained on multiple visits for the majority (54 of 75, 72%) of carriers. The N. lactamica isolates were genetically diverse, with 69 distinct genotypes recovered from the 75 infants. Carriage was generally long-lived, with an average rate of loss of under 1% per week during the 28 weeks following acquisition. Only 11 of the 75 infants carried more than one genotypically unique isolate during the course of the study. Some participants shared identical isolates with siblings, but none shared identical isolates with their parents. These findings have implications for the design of vaccines based on this organism.
乳酸奈瑟菌是一种主要存在于婴儿上呼吸道的无害人体共生菌,与具有全球重要意义的病原体脑膜炎奈瑟菌密切相关。乳酸奈瑟菌的定植可能是儿童期对脑膜炎球菌病免疫力增强的原因,而儿童期脑膜炎球菌携带率较低。这一观察结果表明,乳酸奈瑟菌全细胞或其成分可能是新型脑膜炎球菌疫苗的潜在成分。然而,人们对儿童中乳酸奈瑟菌的携带动态和种群多样性了解甚少,这给用于疫苗开发的代表性菌株的选择带来了困难。通过对两项婴儿细菌携带纵向研究中分离出的乳酸奈瑟菌进行多位点序列分型,解决了这个问题。这两项研究分别包括100名和216名受试者,乳酸奈瑟菌携带情况分别从4周龄监测至96周龄以及从2周龄监测至24周龄。观察到的最高携带率在56周龄时为44%,大多数携带者(75名中的54名,72%)在多次访视时获得了分离株。乳酸奈瑟菌分离株具有遗传多样性,从75名婴儿中分离出了69种不同的基因型。携带通常具有长期性,在获得后的28周内平均每周丢失率低于1%。在研究过程中,75名婴儿中只有11名携带了一种以上基因型独特的分离株。一些参与者与兄弟姐妹共享相同的分离株,但没有人与他们的父母共享相同的分离株。这些发现对基于该生物体的疫苗设计具有启示意义。